Meghmani Organics quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	543	614	−11.5%
EBITDA	97.9	66.9	+46.4%
EBITDA margin	18.0%	10.9%	+7.1 pts
Profit before tax	67.0	24.3	+175.7%
Net profit	48.2	12.7	+280.0%
EPS	₹1.90	₹0.50	+280.0%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	543	474	509	577	614	553	569	544	414	410	352	379	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	11.9	37.2	14.8	27.8	16.6	13.9	9.1	12.0	8.9	8.9	9.6	12.1
	555	512	524	605	630	567	578	556	423	419	361	391
	301	262	319	350	316	291	370	368	257	295	222	182
	17.2	11.5	5.3	5.1	16.3	−0.7	4.5	7.5	5.1	5.0	5.9	6.9
	−28.1	27.5	−20.1	−13.3	46.3	21.8	−30.1	−30.7	0.8	−50.5	3.1	44.1
	33.7	32.0	37.1	36.7	29.6	29.7	28.2	28.6	27.8	28.6	27.8	30.0
	13.1	20.5	18.1	23.8	29.5	19.3	12.9	26.2	10.6	2.5	26.6	12.8
	29.8	29.3	29.9	30.0	29.7	29.5	29.7	25.5	23.5	22.8	23.1	22.7
	121	121	130	146	139	147	155	140	117	129	101	108
	488	504	519	579	606	537	570	565	442	433	409	407
	97.9	19.7	37.7	52.1	66.9	65.5	40.8	30.6	5.9	2.0	−7.8	7.6
	68.1	−9.6	7.8	22.1	37.2	36.0	11.2	5.1	−17.6	−20.8	−30.9	−15.1
Profit
	67.0	7.2	4.5	26.1	24.3	30.5	7.4	−9.2	−19.3	−14.3	−47.9	−15.8
	67.0	7.2	4.5	26.1	24.3	30.5	7.4	−9.2	−19.3	−14.3	−47.9	−15.8
	18.1	2.3	8.5	14.4	11.3	1.7	0.0	1.8	2.1	2.1	2.6	0.0
	0.7	−3.1	−0.5	0.2	0.4	9.1	11.8	−1.7	−4.6	1.6	−12.3	−0.4
	18.8	−0.9	8.0	14.5	11.6	10.7	11.8	0.1	−2.6	3.6	−9.7	−0.4
	−0.0	−0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	48.2	8.0	−3.5	11.6	12.7	19.8	−4.4	−9.3	−16.8	−18.0	−38.2	−15.3
	48.2	8.0	−3.5	11.6	12.7	19.8	−4.4	−9.3	−16.8	−18.0	−38.2	−15.3
	0.2	1.3	−0.8	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.3	0.2
	48.4	9.3	−4.4	11.7	13.0	20.1	−4.2	−9.0	−16.5	−17.8	−37.9	−15.2
	48.2	8.0	−3.5	11.6	12.7	19.8	−4.4	−9.3	−16.8	−18.0	−38.2	−15.3
Per share
	₹1.90	₹0.32	−₹0.14	₹0.45	₹0.50	₹0.78	−₹0.17	−₹0.36	−₹0.25	−₹0.71	−₹1.50	−₹0.60
	₹1.90	₹0.32	−₹0.14	₹0.45	₹0.50	₹0.78	−₹0.17	−₹0.36	−₹0.25	−₹0.71	−₹1.50	−₹0.60
Other comprehensive income — detail
	0.2	1.3	−0.8	0.2	0.3	0.3	—	—	—	—	—	—
	0.3	1.5	−1.1	0.4	0.4	0.4	0.3	0.3	0.3	0.2	0.4	0.4
	0.1	0.4	−0.3	0.1	0.1	0.1	—	—	—	—	—	—
	—	—	—	—	—	—	0.1	0.1	0.1	0.0	0.1	0.1
	−0.0	0.2	0.0	−0.2	−0.0	−0.0	−0.1	−0.0	0.0	0.0	−0.0	−0.2
	−0.0	0.0	0.0	−0.0	−0.0	−0.0	—	—	—	—	—	—
	—	—	—	—	—	—	−0.0	−0.0	0.0	0.0	−0.0	−0.0
	48.4	9.3	−4.4	11.7	13.0	20.1	−4.2	−9.0	−16.5	−17.8	−37.9	−15.2
Per share — as-filed variants
	₹1.90	₹0.32	−₹0.14	₹0.45	₹0.50	₹0.78	−₹0.17	−₹0.36	−₹0.25	−₹0.71	−₹1.50	−₹0.60
	₹1.90	₹0.32	−₹0.14	₹0.45	₹0.50	₹0.78	−₹0.17	−₹0.36	−₹0.25	−₹0.71	−₹1.50	−₹0.60
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	253	173	205	235	235	242	224	199	151	160	121	146
	46.6%	36.4%	40.2%	40.8%	38.3%	43.7%	39.4%	36.6%	36.5%	39.0%	34.4%	38.5%
Adjusted (ex-exceptional items) — derived
	67.0	7.2	4.5	26.1	24.3	30.5	7.4	−9.2	−19.3	−14.3	−47.9	−15.8
	48.2	8.0	−3.5	11.6	12.7	19.8	−4.4	−9.3	−16.8	−18.0	−38.2	−15.3
	₹1.90	₹0.32	−₹0.14	₹0.45	₹0.50	₹0.78	−₹0.17	−₹0.36	−₹0.25	−₹0.71	−₹1.50	−₹0.60

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MOL₹55.04

Meghmani Organics Limited

· Chemicals

Annual Quarterly₹ CrorePeersIPL PUNJABCHEM INSECTICID ASTEC BHARATRAS DHARMAJ GSPCROP ADVANCEMcap ₹1,400 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	378.7	351.8	410.0	413.9	543.9	568.5	553.5	613.6	577.3	508.7	474.3	542.8
Other Income	12.1	9.6	8.9	8.9	12.0	9.1	13.9	16.6	27.8	14.8	37.2	11.9
Total Income	390.8	361.4	419.0	422.8	555.9	577.6	567.3	630.2	605.0	523.6	511.6	554.8
Expenses
+ Cost of Materials Consumed	182.1	221.9	295.3	256.9	368.0	370.3	290.6	315.9	350.2	319.1	262.5	301.0
+ Purchases of Stock-in-Trade	6.9	5.9	5.0	5.1	7.5	4.5	-0.7	16.3	5.1	5.3	11.5	17.2
+ Changes in Inventories	44.1	3.1	-50.5	0.8	-30.7	-30.1	21.8	46.3	-13.3	-20.1	27.5	-28.1
+ Employee Benefit Expense	30.0	27.8	28.6	27.8	28.6	28.2	29.7	29.6	36.7	37.1	32.0	33.7
+ Finance Costs	12.8	26.6	2.5	10.6	26.2	12.9	19.3	29.5	23.8	18.1	20.5	13.1
+ Depreciation & Amortisation	22.7	23.1	22.8	23.5	25.5	29.7	29.5	29.7	30.0	29.9	29.3	29.8
+ Other Expenses	108.1	100.9	129.4	117.4	140.0	154.8	146.6	138.6	146.4	129.7	121.2	121.2
Total Expenses	406.6	409.3	433.3	442.1	565.0	570.2	536.8	605.9	578.9	519.1	504.4	487.8
EBITDA	7.6	-7.8	2.0	5.9	30.6	40.8	65.5	66.9	52.1	37.7	19.7	97.9
EBIT	-15.1	-30.9	-20.8	-17.6	5.1	11.2	36.0	37.2	22.1	7.8	-9.6	68.1
Profit
PBT before Exceptional Items	-15.8	-47.9	-14.3	-19.3	-9.2	7.4	30.5	24.3	26.1	4.5	7.2	67.0
Pretax Income	-15.8	-47.9	-14.3	-19.3	-9.2	7.4	30.5	24.3	26.1	4.5	7.2	67.0
+ Current Tax	0.0	2.6	2.1	2.1	1.8	0.0	1.7	11.3	14.4	8.5	2.3	18.1
+ Deferred Tax	-0.4	-12.3	1.6	-4.6	-1.7	11.8	9.1	0.4	0.2	-0.5	-3.1	0.7
Tax Expense	-0.4	-9.7	3.6	-2.6	0.1	11.8	10.7	11.6	14.5	8.0	-0.9	18.8
+ Share of Associates & JVs	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.0	-0.0
Net Income	-15.3	-38.2	-18.0	-16.8	-9.3	-4.4	19.8	12.7	11.6	-3.5	8.0	48.2
+ Net Income — Continuing Ops	-15.3	-38.2	-18.0	-16.8	-9.3	-4.4	19.8	12.7	11.6	-3.5	8.0	48.2
+ Other Comprehensive Income	0.2	0.3	0.2	0.3	0.3	0.2	0.3	0.3	0.2	-0.8	1.3	0.2
Total Comprehensive Income	-15.2	-37.9	-17.8	-16.5	-9.0	-4.2	20.1	13.0	11.7	-4.4	9.3	48.4
Net Income to Common	-15.3	-38.2	-18.0	-16.8	-9.3	-4.4	19.8	12.7	11.6	-3.5	8.0	48.2
Per Share
Basic EPS	-0.60	-1.50	-0.71	-0.25	-0.36	-0.17	0.78	0.50	0.45	-0.14	0.32	1.90
Diluted EPS	-0.60	-1.50	-0.71	-0.25	-0.36	-0.17	0.78	0.50	0.45	-0.14	0.32	1.90
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	0.3	0.3	0.2	-0.8	1.3	0.2
+ Items NOT to be Reclassified to P&L	0.4	0.4	0.2	0.3	0.3	0.3	0.4	0.4	0.4	-1.1	1.5	0.3
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	0.1	0.1	0.1	-0.3	0.4	0.1
+ Tax on Items NOT to be Reclassified — alt tag	0.1	0.1	0.0	0.1	0.1	0.1	—	—	—	—	—	—
+ Items to be Reclassified to P&L	-0.2	-0.0	0.0	0.0	-0.0	-0.1	-0.0	-0.0	-0.2	0.0	0.2	-0.0
+ Tax on Items to be Reclassified	—	—	—	—	—	—	-0.0	-0.0	-0.0	0.0	0.0	-0.0
+ Tax on Items to be Reclassified — alt tag	-0.0	-0.0	0.0	0.0	-0.0	-0.0	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	-15.2	-37.9	-17.8	-16.5	-9.0	-4.2	20.1	13.0	11.7	-4.4	9.3	48.4
Per Share — as-filed variants
Basic EPS — Continuing Operations	-0.60	-1.50	-0.71	-0.25	-0.36	-0.17	0.78	0.50	0.45	-0.14	0.32	1.90
Diluted EPS — Continuing Operations	-0.60	-1.50	-0.71	-0.25	-0.36	-0.17	0.78	0.50	0.45	-0.14	0.32	1.90
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	145.7	120.9	160.1	151.1	199.2	223.8	241.7	235.2	235.3	204.5	172.9	252.7
Gross Margin %	38.47	34.36	39.05	36.51	36.62	39.37	43.68	38.32	40.75	40.20	36.45	46.56
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	-15.8	-47.9	-14.3	-19.3	-9.2	7.4	30.5	24.3	26.1	4.5	7.2	67.0
Net Income Adj (tax-effected)	-15.3	-38.2	-18.0	-16.8	-9.3	-4.4	19.8	12.7	11.6	-3.5	8.0	48.2
EPS Adj	-0.60	-1.50	-0.71	-0.25	-0.36	-0.17	0.78	0.50	0.45	-0.14	0.32	1.90
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	25.4	25.4	25.4	25.4	25.4	25.4	25.4	25.4	25.4	25.4	25.4	25.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Meghmani Organics Q2 FY27 results date

Meghmani Organics (NSE: MOL) will announce its Q2 FY27 results (July–September 2026) on Wednesday, 4 November 2026, according to the board-meeting notice it filed on 28 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹48.2 crore, up 280.0% from ₹12.7 crore in Q1 FY26 and up 500.1% from ₹8 crore in Q4 FY26. Revenue from operations was ₹543 crore, down 11.5% year on year and up 14.4% from the previous quarter.

Board-meeting notice filed: 28 October 2026
Q2 FY26 results (a year earlier): 8 November 2025
Q1 FY27 results (the latest): 29 July 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 4 November 2026Wednesday · notice filed 28 Oct
Q1 FY27 net profit: ₹48.2 Cr+280.0% vs Q1 FY26+500.1% vs Q4 FY26
Q1 FY27 revenue: ₹543 Cr−11.5% vs Q1 FY26+14.4% vs Q4 FY26
Q1 FY27 operating margin: 12.5%+6.5 pts vs Q1 FY26+14.6 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹11.6 CrRevenue ₹577 Cr
Q1 FY27 EPS (basic): ₹1.90

Questions

When will Meghmani Organics announce its Q2 FY27 results?

On 4 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 28 October 2026). Last year it reported Q2 FY26 on 8 November 2025.

What were Meghmani Organics' Q1 FY27 results?

Consolidated net profit was ₹48.2 crore, up 280.0% from ₹12.7 crore in Q1 FY26 and up 500.1% from ₹8 crore in Q4 FY26. Revenue from operations was ₹543 crore, down 11.5% year on year and up 14.4% from the previous quarter.

What was Meghmani Organics' revenue in FY26?

Revenue from operations was ₹2,174 crore in FY26 (April 2025–March 2026), up 4.5% from ₹2,080 crore in FY25. It was ₹1,566 crore in FY24 and ₹2,553 crore in FY23: down 14.8% over three years, an average fall of 5.2% a year.

What will Meghmani Organics' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹11.6 crore and revenue from operations ₹577 crore. The latest quarter, Q1 FY27, had a net profit of ₹48.2 crore and revenue of ₹543 crore.

How has Meghmani Organics' profit changed over the last four quarters?

Net profit by quarter: a profit of ₹11.6 crore in Q2 FY26, a loss of ₹3.5 crore in Q3 FY26, a profit of ₹8 crore in Q4 FY26 and a profit of ₹48.2 crore in Q1 FY27. That is a combined profit of ₹64.2 crore over the four quarters, up 241.0% from ₹18.8 crore in the four quarters before. Revenue from operations: ₹577 crore, ₹509 crore, ₹474 crore and ₹543 crore.

What was Meghmani Organics' net profit in FY26?

Consolidated net profit was ₹28.7 crore in FY26 (April 2025–March 2026), against a loss of ₹10.6 crore in FY25. It was a loss of ₹106 crore in FY24 and a profit of ₹238 crore in FY23: down 87.9% over three years, an average fall of 50.6% a year.

Where do these Meghmani Organics figures come from?

From Meghmani Organics' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.